Internal Medicine · Elkton, MD
NPI
1962734079
Since 2010
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
106 Bow St
Elkton, MD, 21921
Phone (410) 398-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
4,796 services
Medicare patients, 2024
24
Average age 63
Drug cost, 2024
$1.8M
1,366 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Manpreet K Sidhu prescribed most often to Medicare patients was Anastrozole, with 276 prescriptions and refills. In total Manpreet K Sidhu wrote 1,366 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 276 | 829 | 113 | $7,827 |
| Letrozole Generic | 243 | 720 | 84 | $4,978 |
| Tamoxifen Citrate Generic | 162 | 539 | 68 | $4,317 |
| Prochlorperazine Maleate Generic | 55 | 55 | 33 | $762 |
| Ondansetron Hcl Generic | 50 | 50 | 25 | $387 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 43 | 43 | 19 | $728 |
| Nivestym Filgrastim-Aafi | 31 | 31 | 12 | $45K |
| Dexamethasone Generic | 31 | 32 | 22 | $511 |
| Duloxetine Hcl Generic | 30 | 62 | Under 11 | $546 |
| Entecavir Generic | 29 | 29 | Under 11 | $384 |
| Ibrance Palbociclib | 26 | 26 | Under 11 | $401K |
| Veozah Fezolinetant | 25 | 31 | Under 11 | $19K |
| Lorazepam Generic | 25 | 25 | 13 | $210 |
| Lenvima Lenvatinib Mesylate | 22 | 22 | Under 11 | $453K |
| Exemestane Generic | 20 | 60 | Under 11 | $1,615 |
Brand drugs: 169 claims; generic drugs: 1,197 claims; opioid claims: 83.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Manpreet K Sidhu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.